Skip to main content

Anna Rosell Novel

Graduated in Biology (2001) and PhD in Medicine (2005), both at Universitat Autònoma de Barcelona. My scientific education and expertise has been focused in the translational study of stroke disease and therapies. I obtained a Miguel Servet research position in 2010 from the Spanish National Institute of Health and Research Agency (Instituto Carlos III), and since February 2016 I hold a Tenure position at VHIR as Principal Investigator and Head of the Neurovascular Research Laboratory.

Institutions of which they are part

Head of group
Neurovascular Diseases
Vall Hebron Institut de Recerca
Anna Rosell Novel

Anna Rosell Novel

Anna Rosell Novel

Institutions of which they are part

Head of group
Neurovascular Diseases
Vall Hebron Institut de Recerca

Graduated in Biology (2001) and PhD in Medicine (2005), both at Universitat Autònoma de Barcelona. My scientific education and expertise has been focused in the translational study of stroke disease and therapies. I obtained a Miguel Servet research position in 2010 from the Spanish National Institute of Health and Research Agency (Instituto Carlos III), and since February 2016 I hold a Tenure position at VHIR as Principal Investigator and Head of the Neurovascular Research Laboratory.

As a PhD student at Vall d’Hebron Research Institute (VHIR) I was trained in the biomarkers field and clinical stroke studies, which gave me a solid understanding of the disease from a clinical perspective. After I moved to the United States for a Postdoctoral position at the Massachusetts General Hospital in a world-leading laboratory recognized for their experimental studies in cerebral ischemia (Neuroprotection Research Laboratory-MGH), which offered me the opportunity to extend my experience at a more basic and experimental level. I obtained a Miguel Servet position in 2010 from the Spanish National Institute of Health and Research Agency (Instituto Carlos III), and since February 2016 I hold a Tenure position at VHIR as Principal Investigator and since 2017 I am the head of the Neurovascular Research Laboratory. The main focus of my research is the search of new therapies for stroke patients based on neurorepair strategies with specific emphasis on the role of angio-vasculogenesis using nanomedicine and cell-therapy approaches for regenerative medicine. This has allowed me to obtain independent funding as PI from national agencies, Euronanomed program and private foundations, to supervise and guide PhD Students, Post-doctoral researchers, and establish national and International collaborations with other PIs in the neuroscience, regenerative medicine and nanotechnology fields. I do have the research accreditation of Associate Professor from AQU. My group has a distinction of Consolidated Research Group by AGAUR (2017SGR 1427) and belongs to the Spanish Cooperative Network for Research in Cerebrovascular Diseases (RICORS-2022).

Projects

Uso de nanopartículas magnéticas para la potenciación de la neuroreparación tras el ictus isquémico mediante la dirección localizada de células endoteliales progenitoras

IP: Anna Rosell Novel
Collaborators: -
Funding agency: Instituto de Salud Carlos III
Funding: 111320
Reference: PI10/00694
Duration: 01/01/2011 - 30/04/2014

Neurorepair Treatments for Cerebral Ischemia using Endothelial Progenitor Cells (EPCs)

IP: Anna Rosell Novel
Collaborators: -
Funding agency: Instituto de Salud Carlos III
Funding: 45000
Reference: CP09/00265
Duration: 01/01/2010 - 31/05/2013

Neurorepair Treatments for Cerebral Ischemia using Endothelial Progenitor Cells (EPCs)

IP: Joan Montaner Villalonga
Collaborators: Anna Rosell Novel, Laia Perez Lasarte
Funding agency: Instituto de Salud Carlos III
Funding: 243000
Reference: MS09/00265
Duration: 16/02/2010 - 15/02/2016

European Stroke Research Network

IP: Joan Montaner Villalonga
Collaborators: José Alvarez Sabin, Carlos Molina Cateriano, Anna Rosell Novel
Funding agency: Ministerio de Ciencia e Innovación-MICINN
Funding: 97000
Reference: EUS2008-03610
Duration: 01/01/2009 - 28/02/2013

Ministerio de Ciencia

Related news

The TOUCH MSCA-COFUND doctoral training programme, led by UAB and focusing on the field of mental health, has opened its first call for applications, offering 13 doctoral positions.

The Cardiovascular Diseases and Neurovascular Diseases groups at VHIR will investigate new therapeutic strategies for heart failure, nanomedicine in stroke and the prevention of cardiovascular toxicity in the case of oncological treatments.

La recerca és fonamental per contrarestar els efectes de la pol·lució, que segons l’AEMPS, va ser la causa de més de 300.000 morts prematures a la UE el 2020.

Related professionals

Adria Aterido Ballonga

Adria Aterido Ballonga

Postdoctoral researcher
Rheumatology
Read more
Mònica Pons Delgado

Mònica Pons Delgado

Predoctoral researcher
Liver Diseases
Read more
Elena Granell  Pallares

Elena Granell Pallares

Administration and Management
Rheumatology
Read more
David Gurwitz

David Gurwitz

Senior researcher
Systemic Diseases
Read more

Subscribe to our newsletters and be part of the Campus life

We are a world-leading healthcare complex where healthcare, research, teaching and innovation go hand in hand.

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.